Epidermal IL-15Rα acts as an endogenous antagonist of psoriasiform inflammation in mouse and man

Epidermal IL-15Rα, shed by keratinocytes upon stimulation with inflammatory cytokines, counteracts IL-15–induced proliferation of IL-17–producing T cells to dampen psoriatic skin disease.

[1]  J. Krueger.  Hiding under the skin: A welcome surprise in psoriasis , 2012, Nature Medicine.

[2]  S. Werner,et al.  Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. , 2012, The Journal of clinical investigation.

[3]  B. Becher,et al.  Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. , 2012, The Journal of clinical investigation.

[4]  J. Sprent,et al.  Homeostatic maintenance of T cells and natural killer cells , 2012, Cellular and Molecular Life Sciences.

[5]  Subhashis Banerjee,et al.  Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. , 2012, The New England journal of medicine.

[6]  J. Ortonne,et al.  Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. , 2012, The New England journal of medicine.

[7]  F. Nestle,et al.  The multitasking organ: recent insights into skin immune function. , 2011, Immunity.

[8]  V. Jala,et al.  Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. , 2011, Immunity.

[9]  A. Hayday,et al.  Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis , 2011, The Journal of Immunology.

[10]  G. Pantaleo,et al.  Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells , 2010, Proceedings of the National Academy of Sciences.

[11]  J. Galmiche,et al.  Interleukin-15 and its soluble receptor mediate the response to infliximab in patients with Crohn's disease. , 2010, Gastroenterology.

[12]  Frank O. Nestle,et al.  Mechanisms of Disease: Psoriasis. , 2009 .

[13]  L. Boon,et al.  Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1 , 2009, The Journal of Immunology.

[14]  A. Plet,et al.  The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha. , 2008, Journal of molecular biology.

[15]  A. Plet,et al.  230 The exon 3-encoded domain of IL-15Ralpha contributes to IL-15 high-affinity binding and is crucial for IL-15 antagonistic effect of soluble IL-15Ralpha , 2008 .

[16]  I. Mellman,et al.  Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide , 2007, Nature.

[17]  O. Boyman,et al.  α1β1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis , 2007, Nature Medicine.

[18]  James G. Krueger,et al.  Pathogenesis and therapy of psoriasis , 2007, Nature.

[19]  O. Boyman,et al.  The pathogenic role of tissue-resident immune cells in psoriasis. , 2007, Trends in immunology.

[20]  L. Lefrançois,et al.  Combined IL-15/IL-15Rα Immunotherapy Maximizes IL-15 Activity In Vivo1 , 2006, The Journal of Immunology.

[21]  J. Sprent,et al.  Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Ottenhoff,et al.  Divergent effects of IL‐12 and IL‐23 on the production of IL‐17 by human T cells , 2006, European journal of immunology.

[23]  P. Parren,et al.  Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. , 2005, Arthritis and rheumatism.

[24]  O. Boyman,et al.  Plasmacytoid predendritic cells initiate psoriasis through interferon-α production , 2005, The Journal of experimental medicine.

[25]  P. Perrin,et al.  Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. , 2005, Immunity.

[26]  R. Dummer,et al.  Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. , 2004, Archives of dermatology.

[27]  P. Burkett,et al.  Coordinate Expression and Trans Presentation of Interleukin (IL)-15Rα and IL-15 Supports Natural Killer Cell and Memory CD8+ T Cell Homeostasis , 2004, The Journal of experimental medicine.

[28]  Frank O. Nestle,et al.  Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-α , 2004, The Journal of experimental medicine.

[29]  L. Lefrançois,et al.  Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+ bone marrow-derived cells. , 2004, Blood.

[30]  P. Parren,et al.  Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. , 2003, The Journal of clinical investigation.

[31]  T. Waldmann,et al.  IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells , 2002 .

[32]  Christine A. Biron,et al.  Coordinated and Distinct Roles for IFN-αβ, IL-12, and IL-15 Regulation of NK Cell Responses to Viral Infection1 , 2002, The Journal of Immunology.

[33]  Steffen Jung,et al.  In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. , 2002, Immunity.

[34]  J. Schwartzman,et al.  Treatment with Soluble Interleukin-15Rα Exacerbates Intracellular Parasitic Infection by Blocking the Development of Memory CD8+ T Cell Response , 2002, The Journal of experimental medicine.

[35]  U. Chaudhari,et al.  Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial , 2001, The Lancet.

[36]  K. Asadullah,et al.  Inhibition of Keratinocyte Apoptosis by IL-15: A New Parameter in the Pathogenesis of Psoriasis?1 , 2000, The Journal of Immunology.

[37]  P. Mease,et al.  Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial , 2000, The Lancet.

[38]  P. Morrissey,et al.  Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice , 2000, The Journal of experimental medicine.

[39]  F. Magrangeas,et al.  Natural Splicing of Exon 2 of Human Interleukin-15 Receptor α-Chain mRNA Results in a Shortened Form with a Distinct Pattern of Expression* , 1999, The Journal of Biological Chemistry.

[40]  T. Dassopoulos,et al.  IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. , 1998, Immunity.

[41]  I. McInnes,et al.  Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. , 1998, Journal of immunology.

[42]  I. McInnes,et al.  Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis. , 1998, Immunology today.

[43]  V. Dixit,et al.  Keratinocytes as initiators of inflammation , 1991, The Lancet.

[44]  O. Boyman,et al.  Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. , 2007, Nature medicine.

[45]  Leo Lefrançois,et al.  Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. , 2006, Journal of immunology.

[46]  I. Weissman,et al.  Langerhans cells renew in the skin throughout life under steady-state conditions , 2003, Nature Immunology.

[47]  T. Waldmann,et al.  IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. , 2002, Immunity.

[48]  A. Khanolkar,et al.  T cell responses to viral infections , 2002, Immunologic research.

[49]  T. Waldmann,et al.  The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. , 1999, Annual review of immunology.